Previously, CAR-T therapy required an inpatient hospital stay, but the center is shifting some patients to its outpatient infusion center to receive treatment. The shift will begin in late July, according to a July 5 system news release.
UVA Cancer Center shifts CAR-T therapy to outpatient setting
Charlottesville, Va.-based UVA Cancer Center is offering some patients chimeric antigen receptor T-cell therapy in an outpatient setting.
The Competency Revolution: A Practical Model for Consistent Performance and Sustained Development
Presenters: Joel Ray, COL, USAF, NC, MSN, RN, NEA-BC, Laudio and StaffGarden by Ascend LearningLarissa Africa, MBA, RN, CENP, FAONL, FAAN, StaffGarden by Ascend LearningAlicia Potolsky, DNP, RN, NE-BC, DipACLM, El Camino HealthJulie Balluck, DNP, RN, NEA-BC, Texas Health Resources
Comments are closed.